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Abstract
Background: Chikungunya virus (CHIKV) infections have been reported sporadically within the 
last 5 years in several areas of Indonesia including Bali. Most of the reports, however, have lacked 
laboratory confirmation.
Method: A recent fever outbreak in a village in the North Bali area was investigated using 
extensive viral diagnostic testing including both molecular and serological approaches.
Results and conclusions: Ten out of 15 acute febrile illness samples were confirmed to have 
CHIKV infection by real-time PCR or CHIKV-specific IgM enzyme-linked immunosorbent assay 
(ELISA). The outbreak strain belonged to the Asian genotype with highest homology to other 
CHIKV strains currently circulating in Indonesia. The results are of public health concern 
particularly because Bali is a popular tourist destination in Indonesia and thereby the potential to 
spread the virus to non-endemic areas is high.
GenBank accession numbers: KY885022, KY885023, KY885024, KY885025, KY885026, 
KY885027.
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Background
Chikungunya virus (CHIKV), an alphavirus, typically causes a clinical syndrome 
characterized by fever, rash and arthralgia. Recent CHIKV outbreaks have been reported in 
several areas of Indonesia, including Bali, from 2009 to 2011.1 However, the determination 
of CHIKV outbreaks in Indonesia has been based mainly on clinical data and laboratory 
exclusion of dengue virus (DENV) infection. In addition, information on CHIKV 
characterization from Bali is limited except for reports from travel-acquired cases.2 From 
December 2015 to January 2016, the Bali Provincial Health Office received reports of an 
outbreak of febrile illnesses with rash and arthralgia suspected to be caused by CHIKV 
infection in Nagasepaha Village, Buleleng, in North Bali. The objective of this study was to 
provide laboratory confirmation and characterization of this CHIKV outbreak in Bali using a 
range of standard assays.
Methods
A community-based study was carried out in patients suspected of recent CHIKV infection 
by the Bali Provincial Health Office through direct observation, interviews and collection of 
biological samples, entomological and environmental data. Out of the 96 suspected cases of 
CHIKV infection, blood samples were collected from 15 cases in the acute stage of illness 
(less than 7 days after onset of fever). Samples were sent to the Biomolecular Laboratory, 
Faculty of Medicine and Health Sciences, Warmadewa University, Bali for DENV reverse 
transcriptase real-time PCR (RT-PCR), and to the Eijkman Institute for Molecular Biology, 
Jakarta, for laboratory confirmation of CHIKV infection.
Chikungunya and dengue virus RT-PCR
Viral RNA was extracted from 140 μl of acute sera using the QIAamp® viral RNA mini kit 
(QIAGEN, Hilden, Germany). RNA was used as a template for CHIKV quantitative RT-PCR 
(qRT-PCR) and DENV nested RT-PCR according to published methods.3,4
Virus isolation and CHIKV genome sequencing
Virus isolation was performed in Vero-81 (African green monkey kidney) cells by 
inoculating the serum samples onto the monolayers followed by incubation at 37°C for up to 
14 d. Cells were observed daily for any indication of cytopathic effects (CPEs) and 
supernatant was assayed using CHIKV qRT-PCR as described above. Positive specimens 
were further assayed to amplify 1320 bases of the CHIKV genome envelope region (E1) as 
previously described5 followed by DNA sequencing.
Anti-CHIKV IgM and IgG ELISA
IgM and IgG antibodies against CHIKV were detected using an in-house IgM/IgG capture 
enzyme-linked immunosorbent assay (ELISA) according to the published methods.6 
Samples containing an antibody titer of ≥40 units were considered positive.
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Entomological survey
A house-to-house survey for larval mosquitoes in water containers in all houses in the 
village was conducted during the outbreak investigation. Data were used to calculate the 
House index (HI; number of houses with positive containers per 100 houses evaluated) to 
determine the potential risk of transmission.7
Results
From 14 December 2015 to 11 January 2016, a suspected CHIKV outbreak was reported in 
Nagasepaha Village, Buleleng, in the north of Bali. The outbreak reached its peak with 53 
cases in the first week of January 2016. In total, 96 suspect cases were reported, with one 
patient requiring hospitalization, while the others recovered with symptomatic treatment.
Serum samples were collected from 15 individuals reported to be in the early phase of 
illness—53.3% (8/15) were female and 46.7% (7/15) were male between the ages of 19 and 
73 years. Limited clinical data were available during the outbreak, but patients were reported 
to have fever (100%), arthralgia (100%) and skin rash (73.3%).
CHIKV was detected by qRT-PCR in 46.7% (7/15) serum samples with viremia titers 
ranging from 105 to 107 plaque-forming unit (pfu) equivalents/mL (Table 1). Vero-81 cells 
inoculated with the RT-PCR-positive samples also showed CPEs on day 3 post-inoculation. 
CHIKV infection was confirmed from the virus isolation cultures by qRT-PCR assay of the 
supernatants. Genetic characterization of the CHIKV E1 gene showed the Asian genotype 
[GenBank accession nos KY885022–KY885027]. Phylogenetic tree analysis indicated that 
the CHIKV strains from the outbreak were closely related to previous isolates collected from 
various provinces in Indonesia, including Bali, in 2011 and 2013. Additionally, three cases 
with samples collected between days 5 and 7 after clinical onset were classified as recent 
CHIKV infection since samples were positive for anti-CHIKV IgM. Eight cases with 
sufficient remaining sample volume were tested for anti-CHIKV IgG; these showed no 
serological evidence of past CHIKV infection. All 15 specimens were negative for DENV 
by nested RT-PCR.
The mosquito larval survey conducted by the Bali Provincial Health Office showed multiple 
egg laying sites in the houses with a HI of 55%.
Discussion
In 2010, CHIKV infections were reported to have re-emerged sporadically in seven out of 
eight districts in Bali, including Denpasar municipality.1 However, this is the first report 
where extensive diagnostic tools were used to confirm the circulation of CHIKV in Bali. Our 
study documents the re-emergence of CHIKV in Nagasepaha Village, North Bali where 96 
patients were clinically diagnosed, based on fever, rash and arthralgia. Laboratory data 
confirmed nearly half of the acute phase specimens as CHIKV infection with high viral titers 
of 105–107 pfu equivalents/mL. Similarly high titers have been noted elsewhere and reported 
to be associated with high dissemination rates in mosquitoes under appropriate 
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environmental conditions.8 DENV was not detected by RT-PCR in any of the acute 
specimens.
One limitation of our study was the small sample size. With the outbreak reported towards 
the end and with limited resources, only acute-phase specimens were collected to maximize 
the virus recovery.
The entomological survey revealed an abundance of egg-laying sites in the village with an 
HI of 55%. This level is considered by the Ministry of Health Mosquito Control Program to 
indicate a high risk of transmission. While this is only one value reflecting the complex 
vector dynamics, this program uses a cut-off value of 5% to indicate effective mosquito 
control and low risk of mosquito-transmitted disease.7 The high number of houses with 
larvae could potentially increase the viral transmission risk given other appropriate vectorial 
capacity values.
The absence of anti-CHIKV IgG in the samples submitted from 15 cases suggests limited 
population exposure to CHIKV. However, sequencing of the CHIKV strain isolated here 
revealed that it belongs to the Asian genotype closely related to strains known to be 
circulating in Bali and other areas of Indonesia, and associated with relatively mild 
symptoms.9 This suggests that there is ongoing, endemic activity occurring throughout 
Indonesia.
Conclusions
Our study confirmed CHIKV to be the cause of a febrile outbreak in Nagasepaha, North 
Bali, and highlights the re-emergence of CHIKV in Bali. Laboratory confirmation of 
CHIKV is important for public health purposes, especially in dengue-endemic areas, as both 
DENV and CHIKV share the same mosquito vectors and co-circulate. Considering the high 
viremia as found in our study, molecular techniques are clearly a useful tool for an outbreak 
investigation, particularly for samples collected during the acute phase of illness in which 
specific IgM may have not yet developed. Rapid, robust and affordable assays are necessary 
for this underdiagnosed arbovirus, especially in tourist destinations such as Bali.
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